Hers vs PeterMD: Which GLP-1 Provider Is Better?

By Iacob Pastina, Independent Researcher

48 providers verified independently·Independent research·How we rank →

Hers and PeterMD are tied at 7.3/10. PeterMD is more affordable at $165/mo vs $199/mo. Choose Hers for women who want brand-name wegovy (injection or pill) at $149. Choose PeterMD for budget-conscious users looking for the lowest monthly glp-1 .

A side-by-side comparison of Hers and PeterMD covering pricing, scores, medication types, insurance, and more to help you decide.

Hers

#35 of 48

7.3/10

The women's health arm of Hims & Hers Health (NYSE: HIMS). In 2026 Hers signed a direct Novo Nordisk partnership adding FDA-approved Wegovy (pen and pill) at $149/mo and Zepbound via the Lilly partnership — alongside their existing compounded semaglutide and new compounded tirzepatide programs.

Visit Hers

PeterMD

#33 of 48

7.3/10

One of the most affordable compounded GLP-1 options on the market, ideal for budget-conscious patients.

Visit PeterMD

Feature	Hers	PeterMD
Our Score	7.3/10	7.3/10
Starting Price	$199/mo	$165/mo
Medication Type	Both	Compounded
Insurance Accepted	No	No
Best For	Women who want brand-name Wegovy (injection or pill) at $149/mo via the 2026 Novo Nordisk partnership, or a compounded semaglutide option from a publicly traded telehealth brand	Budget-conscious users looking for the lowest monthly GLP-1 cost
Ranking	#35	#33

Pros & Cons Compared

Hers

Pros

+2026 Novo Nordisk partnership — FDA-approved Wegovy pen and Wegovy oral pill from $149/mo, one of the lowest brand-name GLP-1 prices on the market
+Zepbound access via the Lilly/Hims-Hers partnership announced 2026
+Publicly traded company (NYSE: HIMS) with strong financial backing and regulatory compliance
+Broader women's health platform — integrates weight loss with hormonal, skin, and wellness services

Cons

−Membership + medication are billed separately ($39 first month / $149 ongoing membership) — watch the all-in math
−Generic support experience — large patient volume means less personalized attention
−Compounded pricing starts at $199/mo but stepped pricing applies at higher doses
−Zepbound access priced at ~$1,899/mo (brand cash) via the Lilly partnership — read as access, not value

PeterMD

Pros

+Flat $165/mo at all dose levels — price doesn't increase as you titrate up to maintenance doses
+Semaglutide + B12 formulation helps reduce nausea — the most common GLP-1 side effect
+100,000+ patient base with 4.9/5 Trustpilot rating from 14,000+ reviews — strong social proof
+Video consultations with physicians included — real face-to-face medical oversight

Cons

−Only available in 42 states — excluded from 8 states, limiting nationwide access
−Not BBB accredited, with some documented complaints about delayed medication fulfillment
−Originally a testosterone replacement therapy platform — GLP-1 is an expansion, not the core focus

Our Verdict

Hers and PeterMD are closely matched with identical scores of 7.3/10. If budget is your priority, PeterMD starts at $165/mo compared to Hers's $199/mo. Hers offers both brand-name and compounded medications, giving you more flexibility. Choose Hers if you want: women who want brand-name wegovy (injection or pill) at $149/mo via the 2026 novo nordisk partnership, or a compounded semaglutide option from a publicly traded telehealth brand. Choose PeterMD if you want: budget-conscious users looking for the lowest monthly glp-1 cost.

Still undecided? Editor's #1 Overall Pick

Embody

$299/mo · 7.3/10 · Compounded

If neither Hers nor PeterMD feels like the right fit, our overall #1 pick across all 48 GLP-1 telehealth providers is Embody — strongest balance of clinical oversight, transparent pricing, and verified availability.

Visit Embody→Read our full Embody review